Global Narcotic Drugs Market – Industry Trends and Forecast to 2029

Global Narcotic Drugs Market, By Source (Natural, Semi-synthetic, Synthetic), Indication (Pain Management, Cough, Diarrhea, Dysentery, Asthma,  Others), Drug (Opium, Heroin, Codeine, Oxycodone, Hydrocodone, Tramadol, Morphine, Fentanyl, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Narcotic Drugs Market Analysis and Size

The global narcotic drugs market is anticipated to witness substantial growth during the forecast period 2022-2029. Many lead market players are making huge investment in research and development which in turn is boosting the growth of this market. Growing cases of severe pain associated with cancer and arthritis drive the narcotic drug market. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global narcotic drugs market in the forecast period 2022-2029. The expected CAGR of global narcotic drugs market is tend to be around 4.0% in the mentioned forecast period. The market was valued at USD 13 billion in 2021, and it would grow upto USD 17.79 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Narcotic drugs are the kind of addictive substances which affects the cognitive status of the brain and induces euphoria. These drugs are the oldest and strongest pain-relieving agents which cause depression of central nervous system and produce a state of stupor in patients.  

Narcotic Drugs Market Scope and Segmentation

Global Narcotic Drugs Market Dynamics

Drivers

• Increase in Surgical Procedures

According to the National Center for Health Statistics, approximately 48 million surgical inpatient procedures were performed in the United States in 2009. And the procedure is increasing with the rise in minimally invasive surgeries. This boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increased Clinical Studies and Government Initiatives

Rising awareness about the drugs and studies that are conducted for development in identifying the harmful compositions for the body that by government and private companies for better knowledge of these drugs and antidotes is likely to drive the market growth.

• Increasing Demand for Retail Pharmacies

The rise in the number of narcotic drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with these agents could curb the growth of the global antidotes market over a forecast period.

• High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global narcotic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global narcotic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Narcotic Drugs Market         

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

In the post-pandemic era, changes are witnessed in drug use patterns such as increase in the use of cannabis and the non-medical use of pharmaceutical sedatives. The socioeconomic stressors have also boosted the demand for these drugs. Thus, this will leave a significant impact on the narcotic drugs market.

Global Narcotic Drugs Market Scope

The global narcotic drugs market is segmented on the basis of source, indication, drug, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Natural
• Semi-synthetic
• Synthetic

Indication

• Pain Management
• Cough
• Diarrhea
• Dysentery
• Asthma
• Others

Drug

• Opium
• Heroin
• Codeine
• Oxycodone
• Hydrocodone
• Tramadol
• Morphine
• Fentanyl
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Narcotic Drugs Market Regional Analysis/Insights

The global narcotic drugs market is analysed and market size insights and trends are provided by source, indication, drug, distribution channel and end-user as referenced above.

The major countries covered in the global narcotic drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for narcotic drugs market throughout the forecasted period due to increasing incidence of asthma, & severe pain and increased drug abuse.

Asia-Pacific dominates the market due to attracting attention of global leading players to establish numerous emerging economics with significant growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Narcotic Drugs Market Share Analysis

The global narcotic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global narcotic drugs market.

Key players operating in the global narcotic drugs market include:

• Braeburn Inc. (U.S.)
• Takeda Pharmaceutical Company Limited (Japan)
• Johnsons & Johnsons Services Inc (U.S.)
• Boehringer Ingelheim International GmbH (U.S.)
• Allergan (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Sanofi (France)
• AstraZeneca (India)
• GlaxoSmithKline Plc. (U.K.)
• Novartis AG (U.S.)
• Pfizer Inc. (U.S.)
• Amneal Pharmaceuticals LLC. (U.S.)
• Alvogen (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)